Recruiting NCT05480644

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Trial Parameters

Condition Brain Tumor, Primary

Sponsor Duke University

Study Type OBSERVATIONAL

Phase N/A

Enrollment 300

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2022-12-01

Completion 2032-12

All Conditions

Brain Tumor, Primary Brain Metastases, Adult

Brief Summary

The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.

Eligibility Criteria

Inclusion Criteria: * Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate) Exclusion Criteria: * None

Related Trials

NCT07179328

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients

View Trial →

NCT05480644

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE BRAIN TUMOR, PRIMARY TRIALS